Lance David Miller
Lance David Miller
Associate professor of Cancer Biology, Wake Forest School of Medicine
Verified email at wakehealth.edu
Title
Cited by
Cited by
Year
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller, J Smeds, J George, VB Vega, L Vergara, A Ploner, Y Pawitan, ...
Proceedings of the National Academy of Sciences 102 (38), 13550-13555, 2005
13672005
A global map of p53 transcription-factor binding sites in the human genome
CL Wei, Q Wu, VB Vega, KP Chiu, P Ng, T Zhang, A Shahab, HC Yong, ...
Cell 124 (1), 207-219, 2006
12982006
High-fidelity mRNA amplification for gene profiling
E Wang, LD Miller, GA Ohnmacht, ET Liu, FM Marincola
Nature biotechnology 18 (4), 457-459, 2000
8412000
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan, J Bjöhle, L Amler, AL Borg, S Egyhazi, P Hall, X Han, ...
Breast cancer research 7 (6), 1-12, 2005
8252005
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
AV Ivshina, J George, O Senko, B Mow, TC Putti, J Smeds, T Lindahl, ...
Cancer research 66 (21), 10292-10301, 2006
7402006
Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-κB-responsive genes in cervical keratinocytes
M Nees, JM Geoghegan, T Hyman, S Frank, L Miller, CD Woodworth
Journal of virology 75 (9), 4283-4296, 2001
4352001
Ferroportin and iron regulation in breast cancer progression and prognosis
ZK Pinnix, LD Miller, W Wang, R D’Agostino, T Kute, MC Willingham, ...
Science translational medicine 2 (43), 43ra56-43ra56, 2010
3632010
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer
CN Landen, B Goodman, AA Katre, AD Steg, AM Nick, RL Stone, ...
Molecular cancer therapeutics 9 (12), 3186-3199, 2010
3622010
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
S Calza, P Hall, G Auer, J Bjöhle, S Klaar, U Kronenwett, ET Liu, L Miller, ...
Breast Cancer Research 8 (4), 1-9, 2006
3492006
Transcriptome analysis of zebrafish embryogenesis using microarrays
S Mathavan, SGP Lee, A Mak, LD Miller, KRK Murthy, KR Govindarajan, ...
PLoS Genet 1 (2), e29, 2005
3342005
Discovery of estrogen receptor α target genes and response elements in breast tumor cells
CY Lin, A Ström, VB Vega, SL Kong, AL Yeo, JS Thomsen, WC Chan, ...
Genome biology 5 (9), 1-18, 2004
3132004
Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression
SH Lam, YL Wu, VB Vega, LD Miller, J Spitsbergen, Y Tong, H Zhan, ...
Nature biotechnology 24 (1), 73-75, 2006
3052006
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness
E Wang, LD Miller, GA Ohnmacht, S Mocellin, A Perez-Diez, D Petersen, ...
Cancer research 62 (13), 3581-3586, 2002
2972002
Identification of cell cycle-regulated genes in fission yeast
X Peng, RKM Karuturi, LD Miller, K Lin, Y Jia, P Kondu, L Wang, LS Wong, ...
Molecular biology of the cell 16 (3), 1026-1042, 2005
2122005
Optimal gene expression analysis by microarrays
LD Miller, PM Long, L Wong, S Mukherjee, LM McShane, ET Liu
Cancer cell 2 (5), 353-361, 2002
2022002
Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling
SW Nam, JY Park, A Ramasamy, S Shevade, A Islam, PM Long, CK Park, ...
Hepatology 42 (4), 809-818, 2005
1942005
Sal‐like protein 4 (SALL4), a stem cell biomarker in liver cancers
T Oikawa, A Kamiya, M Zeniya, H Chikada, AD Hyuck, Y Yamazaki, ...
Hepatology 57 (4), 1469-1483, 2013
1872013
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome
J Frasor, EC Chang, B Komm, CY Lin, VB Vega, ET Liu, LD Miller, ...
Cancer research 66 (14), 7334-7340, 2006
1862006
An iron regulatory gene signature predicts outcome in breast cancer
LD Miller, LG Coffman, JW Chou, MA Black, J Bergh, R D'Agostino, ...
Cancer research 71 (21), 6728-6737, 2011
1762011
CDKN1C (p57 KIP2) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells
X Yang, RKM Karuturi, F Sun, M Aau, K Yu, R Shao, LD Miller, PBO Tan, ...
PloS one 4 (4), e5011, 2009
1722009
The system can't perform the operation now. Try again later.
Articles 1–20